×

Alnylam Pharmaceuticals and Isis Pharmaceuticals Sue Tekmira Pharmaceuticals

January 20, 2012

Alnylam Pharmaceuticals and Isis Pharmaceuticals filed suit against Tekmira Pharmaceuticals over six patents related to encapsulating compounds in lipid bilayers.  1/17, District of Massachusetts, 1:2012cv10087.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



Related News

×
×